Skip to content
Back to announcement

20240531_MERK_Ringkasan Risalah//Risalah RUPS_31644888_lamp4.pdf

RUPS minutes Needs review MERK

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 3

Page 1 OCR 0.931
PAGRCK

PT Merck Tbk

SUMMARY OF MINUTES OF
ANNUAL GENERAL MEETING OF SHAREHOLDERS

The Board of Directors of PT Merck Tbk (the “Company”) hereby notifies the Company's Shareholders that
the Company has held the Annual General Meeting of Shareholders (the “Meeting”) by physically as well as
electronically (“e-RUPS”) through eASY.KSEI and the Meeting livestream through zoom webinar
AKSes.KSEI facility as provided by PT Kustodian Sentral Efek Indonesia. The Summary of the Minutes of the
Meeting are as follows:

Day, date : Wednesday, 29" May 2024
Time 1 10.18 - 11.21 Western Indonesia Time
Venue : the Company's premises, Jl. TB. Simatupang No. 8, Pasar Rebo, Jakarta Timur

The Meeting Agenda

1. Approval of the Board of Directors' Report regarding the management and financial administration of the
Company for the financial year ended on the 315 December 2023 and Approval of the Statements of
Financial Position of the Company per 31st December 2023 and Statements of Profit or Loss and Other
Comprehensive Income of the Company for the financial year ended on 31s' December 2023, and provide
acguit et de charge to the members of the Board of Directors for all management actions and the exercise
of authority by the members of the Board of Directors and to the members of the Board of Commissioners
for the supervisory actions of the members of the Board of Commissioners during the financial year ended
on 315t December 2023.

2. Stipulation on the use of profits of the Company.
Re-appointment of the members of the Board of Directors of the Company.

4. Appointment of Public Accountant for the financial year ended on the 315t December 2024 and to empower
the Board of Commissioners to stipulate the honorarium of Public Accountant and other reguirements for
its designation.

w

The Meeting was attended by members of the Company's Board of Commissioners and Board of Directors,
namely:

1. Mr. Parulian Simanjuntak (Commissioner/Independent Commissioner),

2. Mrs. Evie Yulin (President Director), and

3. Mr. Bambang Nurcahyo (Director).

The Meeting was attended by Shareholders and/or their Proxies representing 388,310,820 shares or 86.68Yo
of 448,000,000 shares which has been issued by the Company.

During the Meeting Agenda discussion, the shareholders and/or their proxies who attend physically or
electronically were given the opportunity to ask the guestions, opinions, proposals and/or suggestions related
to the agenda of the Meeting are discussed prior the voting sessions.

The resolution making mechanism carried out by verbal and asked to the shareholders and/or their proxies
who physically attend in the Meeting to raise their hands for those vote objections and abstains, while those
vote approve is not being asked to raise their hands. Abstains vote is considered to the same vote as majority
of the voting shareholders. For Shareholders who attend through eASY.KSEI, Meeting resolutions are made
by selecting decisions available on the eASY.KSEI platform that started within 1 (one) minute since the
Meeting Chairman determined to start for the voting time.

Page 1of 3
Page 2 OCR 0.882
PARRCK

PT Merck Tbk
Number ot Total Vote
areholders
An and/or their
Proxies who Agree Disagree Abstain Total Agree 4 Abstain Result
raised guestion
388,308,820 shares 2,000 shares 388,310,820 shares
1 0 (99.9996 of total o (0.018 oftotal | (100.00096 of total
shares present at the shares present | shares presentatthe | APproved
meeting) at the meeting) meeting)
388,308,820 shares 2,000 shares 388,308,820 shares
(99.99996 of total (0.00196 of total (99.99970 of total
2 g shares presentatthe | shares presentat » sharespresentattne | APProved
meeting) the meeting) meeting)
388,308,620 shares 2,000 shares 388,308,820 shares
99.999” of total (0.00196 of total (99.99994 of total
o (
3 sharespresentatthe | shares present at , shares presentatthe | APproved
meeting) the meeting) meeting)
388,308,820 shares 2,000 shares 388,308,820 shares
(99.999 of total (0.00196 of total (99.99976 of total
4 9 sharespresentatthe | shares presentat o shares presentattne | Approved
meeting) the meeting) meeting)

Meeting Resolutions
1. The First Agenda:

a.

b.

Approved the Annual Report of the Company's Board of Directors for the year ended on 31st December
2023.

Approved and ratified the Statement of Financial Position as well as Statement of Profit or Loss and
Other Comprehensive Income of the Company for the financial year ended on 315 December 2023
and grant the acguit et de charge to members of the Board of Directors of the Company for all the
management actions and exercise of authority by members of the Board of Directors, also to members
of the Board of Commissioners of the Company for the supervisory actions of the members of the
Board of Commissioners during the Company's financial year ended on 314 December 2023.

2. The Second Agenda:

a.

b.

Approved the use of the Company's profits for financial year 2023 by distributing the Final Dividend
for the accounting year of 2023 amounting to Rp 320.- (three hundred twenty Rupiah) per share and
approved the distribution procedures of the said Final Dividend to Shareholders/Owner of 448,000,000
(four hundred forty eight million) shares issued by the Company, whose names are registered in the
Shareholders Register of the Company on 10t" June 2024 at 16.00 Western Indonesia Time (Recording
Date), in accordance with the regulations of PT Bursa Efek Indonesia (“Stock Exchange”) for trading
shares on the Stock Exchange, as follows:

Cum Final Dividend at Regular and Negotiated Market 6" June 2024
Ex Final Dividend at Regular dan Negotiated Market 7" June 2024
Cum Final Dividend at Cash Market 10" June 2024
Ex Final Dividend at Cash Market 11" June 2024
Recording Date 10" June 2024
Effective Payment Date of Final Dividend 261" June 2024

Grants the power of attorney to the Board of Directors of the Company to carry out the said dividend
distribution.

Page 20f3
Page 3 OCR 0.931
PAGRCK

PT Merck Tbk

3. The Third Agenda:
a. Accepted and approved the re-appointment of Mrs. Evie Yulin as President Director of the Company,
Mr. Bambang Nurcahyo and Mr. Arryo Aritrixso Teguh Putranto Wachjuwidajat as Director of the
Company, respectively, as of the closing of this Meeting. Therefore, the composition of the Board of
Directors of the Company as of the closing of this Meeting until the closing of the Annual General
Meeting of Shareholders of the Company that will be held in 2027, is as follows:

- President Director : Mrs. Evie Yulin,
- Director : Mr. Bambang Nurcahyo,
- Director : Mr. Arryo Aritrixso Teguh Putranto Wachjuwidajat.

b. To authorize the Board of Directors of the Company and/or staff of the Notary's office, collectively or
individually to represent and act for and on behalf of the Meeting to:

-  declare the decision on the agenda of this third Meeting in a separate deed and notify the Minister
of Law and Human Rights of the Republic of Indonesia regarding the appointment of members of
the Board of Directors of the Company,

- for the above purpose, sign deeds, letters and carry out other actions necessary for notification
to the competent authority.

4. The Fourth Agenda:

a. Approved the appointment of Public Accountant Firm Imelda and Rekan as the Company's Public
Accountant Firm to audit the Company's Statement of Financial Position, Statement of Profit or Loss
Statement and Other Comprehensive Income and other parts of the Company's Financial Report for
accounting year ended on 31“ December 2024.

b. To empower the Company's Board of Commissioners to stipulate the honorarium of the Public
Accountant as mentioned above and other reguirements for the appointment.

Jakarta, 315 May 2024
Board of Directors of the Company

Page 3 of 3

File

File Open PDF
Source IDX
Size0.92 MB
Published31 May 2024
Pages3
Characters7,752
Text sourceOCR
OCR confidence0.915

Names mentioned 8 people and organisations named in the text · linked when the evidence is strong

possible org Merck Tbk p.1 ×8
possible org PT Bursa Efek Indonesia p.2
unresolved org PT Kustodian Sentral Efek Indonesia p.1
unresolved org PT Kustodian Sentral Efek Indonesia. The Summary p.1
unresolved person Parulian Simanjuntak p.1
unresolved person Evie Yulin · President Director p.1 ×5
unresolved person Bambang Nurcahyo · Director p.1 ×3
unresolved person Arryo Aritrixso Teguh Putranto Wachjuwidajat · Director p.3 ×3

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

Rule parser Needs review confidence 0.000 134 ms 13 Sep 2026 16:27

no RUPS minutes content - likely misclassified

↑↓ select ↵ open ⇧↵ see every result